GE HealthCare Technologies (GEHC) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
GE HealthCare Technologies Inc. (GEHC) insider buying and selling: 8 purchases, no sales
78 Form 4 Table I transactions filed with the SEC by GE HealthCare Technologies Inc. insiders between 2025-09-03 and 2026-09-16 (15-month history): 8 open-market purchases and 0 sales, plus 70 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a purchase of $5.0M by Culp H Lawrence Jr on 2026-05-06.
GE HealthCare Technologies insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, GE HealthCare Technologies insiders filed 8 purchases worth $6.4M on the open market, and no sales.
The biggest buyer was Culp H Lawrence Jr (Director): $5.0M in 1 purchase, out of 8 different buyers.
The largest trade of the period was a purchase of $5.0M on May 6, 2026, by Culp H Lawrence Jr (Director). Form 4 on sec.gov (0001205247-26-000006).
The last three months show 0 purchases, against 8 in the three before. The latest purchase is from May 22, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. GE HealthCare Technologies has no sales, like 4 of the other 58, ranks 1 of 59 by net dollars bought, and 19 of the 59 have at least one purchase, GE HealthCare Technologies included.
The 20 most important trades
The 8 open-market purchases first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 78 GEHC trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-05-06 | 2026-05-07 | Culp H Lawrence Jr | Director | $5.0M | P — Open-market purchase Indirect holding, through: By holding company Form 4 footnoteF1 The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | SEC |
| 2026-05-22 | 2026-05-26 | Lobo Kevin | Director | $642k | P — Open-market purchase | SEC |
| 2026-04-30 | 2026-04-30 | Arduini Peter J | President and CEO | $250k | P — Open-market purchase | SEC |
| 2026-05-01 | 2026-05-01 | Saccaro James | Chief Financial Officer | $201k | P — Open-market purchaseForm 4 footnoteF1 The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | SEC |
| 2026-04-30 | 2026-04-30 | Jimenez Frank R | GC & Corporate Secretary | $106k | P — Open-market purchase | SEC |
| 2026-05-12 | 2026-05-13 | Hochman Rodney F | Director | $100k | P — Open-market purchase Indirect holding, through: By family trust | SEC |
| 2026-05-08 | 2026-05-11 | Yang Watkin Phoebe L. | Director | $63k | P — Open-market purchaseForm 4 footnoteF3 The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | SEC |
| 2026-05-06 | 2026-05-07 | Stromberg William J | Director | $62k | P — Open-market purchase | SEC |
| 2026-02-12 | 2026-02-17 | Arduini Peter J | President and CEO | $2.6M | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
| 2025-09-01 | 2025-09-03 | Arduini Peter J | President and CEO | $837k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. | SEC |
| 2026-09-01 | 2026-09-03 | Arduini Peter J | President and CEO | $820k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. | SEC |
| 2026-02-12 | 2026-02-17 | Saccaro James | Chief Financial Officer | $679k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
| 2026-02-12 | 2026-02-17 | Jimenez Frank R | GC & Corporate Secretary | $662k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
| 2026-02-12 | 2026-02-17 | Kass-Hout Taha | Chief Technology Officer | $617k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
| 2026-09-03 | 2026-09-04 | Arduini Peter J | President and CEO | $445k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. | SEC |
| 2025-09-11 | 2025-09-12 | Rott Roland | CEO, Imaging | $354k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. | SEC |
| 2026-05-15 | 2026-05-19 | Bankes Jeannette | CEO, Patient Care Solutions | $347k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. | SEC |
| 2026-02-12 | 2026-02-17 | Rott Roland | CEO, Imaging | $312k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
| 2025-09-11 | 2025-09-12 | Rott Roland | CEO, Imaging | $299k | M — Option exercise | SEC |
| 2026-02-12 | 2026-02-17 | O'Neill Kevin Michael | CEO, PDx | $258k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Sep 3, 2025 and Sep 16, 2026 there is not one open-market sale of GE HealthCare Technologies Inc.: 8 open-market purchases worth $6.4M and zero dollars sold.
Only codes P and S count, where an insider puts in or takes out their own money. A buying balance like GE HealthCare Technologies Inc.'s is the less common case in the S&P 500: its insiders are already paid in stock and still put in their own money. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| F | Tax withholding (shares surrendered for taxes) | 41 | $10.9M |
| A | Grant or award | 28 | $0 |
| P | Open-market purchase | 8 | $6.4M |
| M | Option exercise | 1 | $299k |
| Total | Everything filed in the period | 78 | $17.6M |
28 of the 78 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 20 distinct people or entities have filed GE HealthCare Technologies Inc. transactions: 8 bought on the open market and none sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Culp H Lawrence Jr | Director | 2 | $5.0M (1) | — | 2026-05-11 |
| Lobo Kevin | Director | 3 | $642k (1) | — | 2026-05-26 |
| Arduini Peter J | President and CEO | 8 | $250k (1) | — | 2026-09-04 |
| Saccaro James | Chief Financial Officer | 6 | $201k (1) | — | 2026-05-01 |
| Jimenez Frank R | GC & Corporate Secretary | 8 | $106k (1) | — | 2026-09-04 |
| Hochman Rodney F | Director | 2 | $100k (1) | — | 2026-05-13 |
| Yang Watkin Phoebe L. | Director | 2 | $63k (1) | — | 2026-05-11 |
| Stromberg William J | Director | 2 | $62k (1) | — | 2026-05-11 |
Shown here are the 8 who moved the most money, out of 20. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was May 2026: 6 purchases and 0 sales, worth $6.1M. 13 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 0 | $0 |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 0 | $0 |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 2 | $356k | 0 | $0 |
| May 2026 | 6 | $6.1M | 0 | $0 |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
GE HealthCare Technologies Inc. (GEHC) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
GE HealthCare Technologies's 8 open-market purchases (code P) are the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Sep 16, 2026, and a Form 4 arrives up to two business days after the trade.
14 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.